Correlation between serum adiponectin and risk factors in patients with coronary artery disease

Clinical Laboratory

Volumn 59, Issue 1-2, 2013, Pages 121-126

  Luo, Suxin ^a   Lei, Han ^a   Liu, Qing ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Adiponectin; Coronary artery disease; High sensitivity C reactive protein; Risk factor

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; UNSTABLE ANGINA PECTORIS;

ADENOSINE DIPHOSPHATE; ADIPONECTIN; AGED; ANGINA PECTORIS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 84874587580     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2012.120131     Document Type: Article

References (23)

1. Fuster V, Adimon L, Badimon J, et al. The pathogenesis of coronary artery disease and Acute coronary syndromes. N Engl J Med 1992;326:242-50.
2. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein ADP. Circulation 1999;100:2473-6. (Pubitemid 30005109)
3. Ouchi N, Kihara S, Arita Y, et al. Adipocyte-derived plasma protein, ADP, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 2001;103:1057-63. (Pubitemid 32200177)
4. Yokata T, Oritani K, Takahashi I, et al. ADP, a novel member of soluble defense collagens, negatively regulates the growth of myelo-monocytic progenitors and the functions of macrophages. Blood 2000;96:1723-32. (Pubitemid 30661055)
5. Maeda N, Shimomura I, Kishida K, et al. Diet-induced insulin resistance in mice lacking ADP/ACRP30. Nat Med 2002;8:731-7. (Pubitemid 34778727)
6. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, ADP, in obesity. Biochem Biophys Res Commun 1999;257:79-83. (Pubitemid 29299050)
7. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, ADP, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-9. (Pubitemid 30353893)
8. Nakamura Y, Shimada K, Fukuda D, et al. Implications of plasma concentrations of ADP in patients with coronary artery disease. Heart 2004;90:528-33. (Pubitemid 38530170)
9. Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoAD Pemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 2003;23:85-9. (Pubitemid 36091630)
10. Wolk R, Berger P, Lennon RJ, Brilakis ES, Davison DE, Somers VK. Association between plasma ADP levels and unstable coronary syndromes. Eur Heart J 2007;28:292-8.
11. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma ADP levels and risk of myocardial infarction in men. JAMA 2004;291:1730-7. (Pubitemid 38489895)
12. Seker M, Bilici A, Guler DO, et al. Tissue and serum adiponectin levels in patients with gastric cancer: are there any relations between adiponectin levels and histopathological variables? Hepato-Gastroenterology 2011;58:1841-6.
13. Ross A. Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-26.
14. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of ADP gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002;290:1084-9. (Pubitemid 34687474)
15. Fasshauer M, Kralisch S, Klier M, et al. ADP gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003;301:1045-50. (Pubitemid 36279218)
16. Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, ADP, adheres to injured vascular walls. Horm Metab Res 2000;32:47-50. (Pubitemid 30143606)
17. Ishikawa Y, Akasaka Y, Ishii T, et al. Changes in the distribution pattern of gelatin binding protein of 28 kDa (ADP) in myocardial remodeling after ischaemic injury. Histopathology 2003;42:43-52. (Pubitemid 36062566)
18. Okamoto Y, Kihara S. ADP reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002;106:2767-70. (Pubitemid 35396973)
19. Yamauchi T, Kamon J, Waki H, et al. Globular ADP protected ob/ob mice from diabetes and apoE deficient mice from Atherosclerosis. J Biol Chem 2003;278:2461-8. (Pubitemid 36801322)
20. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with ADP in blood stream and adipose tissue. Circulation 2003;107:671-4. (Pubitemid 36222590)
21. Thamer C, Stefan N, Stumvoll M, Häring H, Fritsche A. Reduced ADP serum levels in smokers. Atherosclerosis 2005;179:421-2. (Pubitemid 40364640)
22. Mallamaci F, Zoccall C, Cuzzola F, et al. ADP in essential hypertension. J Nephrol 2002;15:507-11.
23. Stefan N, Vozarova B, Funahashi T, et al. Plasma ADP concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 2002;51:1884-8. (Pubitemid 34564302)